Vesicure Therapeutics Co., Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vesicure Therapeutics Co., Ltd - overview
Established
2021
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Suzhou, China and established in 2021, Vesicure Therapeutics Co. , Ltd is a biopharmaceutical company that focuses on the development of early exosomal drugs. The company engages in the development of early exosomal drugs. Its main product is the research and development platform for innovative exosomes drugs.
The company will establish a modEXOTM engineering exosome drug delivery platform.
Current Investors
NLVC, Legend Star, YuanBio Venture
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.vesicure.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Vesicure Therapeutics Co., Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.